Qube Research & Technologies (QRT)
FBT icon

Qube Research & Technologies (QRT)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.58M Buy
+5,786
New +$1.5M ﹤0.01% 2423
2026
Q2 		– Sell
-2,461
Closed -$494K – 3660
2026
Q1 		$494K Buy
2,461
+2,365
+2,464% +$489K ﹤0.01% 2740
2025
Q4 		$19.8K Sell
96
-57
-37% -$11.4K ﹤0.01% 3384
2025
Q3 		$27.4K Sell
153
-554
-78% -$94.3K ﹤0.01% 3261
2025
Q2 		$114K Sell
707
-2,301
-76% -$367K ﹤0.01% 3015
2025
Q1 		$512K Buy
3,008
+3,004
+75,100% +$522K ﹤0.01% 2535
2024
Q4 		$665 Buy
+4
New +$683 ﹤0.01% 3391
2024
Q2 		– Sell
-1,050
Closed -$161K – 4077
2024
Q1 		$161K Buy
1,050
+1
+0.1% +$152 ﹤0.01% 3126
2023
Q4 		$166K Sell
1,049
-293
-22% -$42.1K ﹤0.01% 2892
2023
Q3 		$196K Buy
+1,342
New +$204K ﹤0.01% 2413
2023
Q2 		– Sell
-6,052
Closed -$938K – 2573
2023
Q1 		$938K Buy
+6,052
New +$951K ﹤0.01% 1316
2022
Q4 		– Sell
-3,625
Closed -$478K – 2628
2022
Q3 		$478K Buy
3,625
+473
+15% +$66.4K ﹤0.01% 1488
2022
Q2 		$427K Sell
3,152
-1,980
-39% -$273K ﹤0.01% 1473
2022
Q1 		$765K Buy
5,132
+5,076
+9,064% +$751K 0.01% 1312
2021
Q4 		$9K Buy
+56
New +$9.06K ﹤0.01% 2406
2021
Q1 		– Sell
-5,437
Closed -$913K – 2054
2020
Q4 		$913K Buy
5,437
+626
+13% +$102K 0.01% 904
2020
Q3 		$757K Sell
4,811
-11,610
-71% -$1.9M 0.01% 887
2020
Q2 		$2.76M Buy
+16,421
New +$2.58M 0.04% 561
2020
Q1 		– Sell
-7,615
Closed -$1.13M – 1289
2019
Q4 		$1.13M Buy
+7,615
New +$1.05M 0.04% 561

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $121B AUM 21.47% 1-Year Est. Return
Berger Financial Group
Berger Financial Group Plymouth, Minnesota $2.01B AUM 15.82% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Nilsine Partners
Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FBT Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 5,786 shares worth $1.58M. The stake represents ﹤0.01% of the portfolio and ranks #2423 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in FBT as recently as Q1 2026.

Qube Research & Technologies (QRT) first reported a position in FBT in Q4 2019 and has held it in 19 quarters since. The position peaked at $2.76M in Q2 2020. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Qube Research & Technologies (QRT) held 5,786 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.58M as of Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2423 holding.
  • Qube Research & Technologies (QRT) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 19 quarters since.
  • Qube Research & Technologies (QRT)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.76M in Q2 2020.
  • 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.